Suppr超能文献

谢氏丙酸杆菌生物活性突变体的筛选及其用于肠道菌群失调综合治疗的可能性。

Selection of a biologically active mutant of Propionibacterium shermanii and the possibility of its use in complex therapy of enteral dysbacteriosis.

作者信息

Sidorchuk I I, Bondarenko V M

出版信息

J Hyg Epidemiol Microbiol Immunol. 1984;28(3):331-8.

PMID:6548487
Abstract

A marked, stable mutant of Propionibacterium shermanii T-73, polyresistant to antibiotics, displaying a broad spectrum of antagonistic effect and enhancing synthesis of vitamins B1, B2, B12 and C was obtained. On the basis of the selected mutant, a sour milk product (propioni-acidophilic milk) was prepared and used with good results in complex therapy of intestinal dysbacteriosis in 1148 children aged 4 to 18 months. The administration of propioni-acidophilic milk for a period of 5-12 days led to restoration of the impaired composition of normal microflora and to reconstitution of quantitative relations between the representatives of microbiocoenosis in the distal portions of the large intestine, thus shortening the time of convalescence and rehabilitation of children suffering from acute and chronic inflammatory diseases of the gastrointestinal tract with symptoms of dysbacteriosis.

摘要

获得了谢氏丙酸杆菌T-73的一个显著、稳定的突变体,它对多种抗生素具有抗性,表现出广泛的拮抗作用,并能增强维生素B1、B2、B12和C的合成。基于所选择的突变体,制备了一种酸乳制品(嗜丙酸乳),并将其用于1148名4至18个月大儿童的肠道菌群失调综合治疗,效果良好。服用嗜丙酸乳5至12天可使受损的正常微生物群落组成恢复正常,并重建大肠远端微生物群落代表之间的数量关系,从而缩短患有胃肠道急慢性炎症疾病并伴有菌群失调症状儿童的康复和恢复时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验